HBAN
74
-3
OKE
58
3
PG
64
4
VRSK
63
2
EXPE
77
2
TJX
51
3
FOX
55
2
CCI
26
9
DHI
28
-11
XRAY
31
2
MHK
53
-5
ABT
63
-2
NDAQ
70
4
K
66
-2
ICE
69
2
AMGN
33
2
EBAY
47
2
JNPR
65
2
BBY
48
3
MCK
78
3
HBAN
74
-3
OKE
58
3
PG
64
4
VRSK
63
2
EXPE
77
2
TJX
51
3
FOX
55
2
CCI
26
9
DHI
28
-11
XRAY
31
2
MHK
53
-5
ABT
63
-2
NDAQ
70
4
K
66
-2
ICE
69
2
AMGN
33
2
EBAY
47
2
JNPR
65
2
BBY
48
3
MCK
78
3
Financhill
Back

Sunrise New Energy Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
33

EPOW
Sunrise New Energy

Last Price:
$1.00
Seasonality Move:
-8.71%
Buy
66

SRPT
Sarepta Therapeutics

Last Price:
$60.45
Seasonality Move:
13.61%
Sell
33
Sunrise New Energy (EPOW) is a Sell

Is Sunrise New Energy a Buy, Sell or Hold?

  • The current Sunrise New Energy [EPOW] share price is $1.00. The Score for EPOW is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • EPOW is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
66
Sarepta Therapeutics (SRPT) is a Buy

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $60.44. The Score for SRPT is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
  • SRPT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

EPOW Stock Price Chart

What is Sunrise New Energy's stock price today?

  • The Sunrise New Energy share price today is $1.00
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EPOW is experiencing buying pressure, which is a positive indicator for future bullish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $60.44
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.

EPOW Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.13 Buy
Relative Strength Index (14 RSI): 55.54 Buy
Chaikin Money Flow: 4407 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.91 - 1.01) Buy
Bollinger Bands (100): (0.84 - 0.98) Buy

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -6.02 Sell
Relative Strength Index (14 RSI): 43.26 Sell
Chaikin Money Flow: -671213 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (52.37 - 68.59) Sell
Bollinger Bands (100): (75.16 - 127.4) Sell

EPOW Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.99 Buy
20-day SMA: 0.96 Buy
50-day SMA: 0.95 Buy
200-day SMA: 0.92 Buy
8-day EMA: 0.98 Buy
20-day EMA: 0.9 Buy
50-day EMA: 0.62 Buy
200-day EMA: 0.22 Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.3 Buy
20-day SMA: 57.17 Buy
50-day SMA: 80.89 Sell
200-day SMA: 116.12 Sell
8-day EMA: 58.3 Buy
20-day EMA: 61.18 Sell
50-day EMA: 76.52 Sell
200-day EMA: 105.84 Sell

Sunrise New Energy Earnings Growth & EPOW Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.28 per share, a decrease next quarter of $0.51 per share, an increase this year of $3.58 per share, and an increase next year of $6.23 per share.

Sunrise New Energy Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):